Osteoporosis drug may be a promising treatment for therapy-resistant breast cancer
LAS at 10 mg/kg decreased lung metastases in all three mouse models as shown by IHC staining
How Scientists Around the Country are Using the APS to Fight COVID-19
The COVID-19 pandemic has caused a global health emergency, and the response from the scientific community has been similarly global. Scientists from every corner of the world have worked tirelessly to understand more about the SARS-CoV-2 virus that causes the disease, in order to combat it more effectively.
APS Coronavirus Research in the Media Spotlight
Information in the media about coronavirus (COVID-19) research at Argonne and the APS continues to mount.
Argonne Researchers Continue Efforts in the Battle Against COVID-19
Argonne National Laboratory is helping in the fight against COVID-19 in a number of research products, which includes helping the Federal Protective Service (FPS), their co-recipient in the 2020 'ASTORS' Awards Program, to track and map areas affected by COVID-19 by using the Modified Infrastructure Survey Tool (MIST).
Using Protein Structural Information to Understand the Mechanism of an Essential Enzyme for Fighting Tuberculosis
Using Protein Structural Information to Understand the Mechanism of an Essential Enzyme for Fighting Tuberculosis: Antibiotic resistance is a global problem that many scientists are racing to solve. Researchers using the APS gained important insights into understanding the structure and mechanism of a critical enzyme involved in protein synthesis in tuberculosis, work that will form the basis of structure-based drug design efforts aimed at exploiting the unique features of this enzyme in developing new pharmaceuticals.